Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
FGFR1在乳腺浸润性小叶癌中的表达及意义
FGFR2 mutation in 46, XY sex reversal with craniosynostosis
FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis
FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer
FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma
FGFR3 Mutations and the Skin: Report of a Patient with a FGFR3 Gene Mutation, Acanthosis Nigricans, Hypochondroplasia and Hyperinsulinemia and Review of the Literature
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes
FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra
FGFR3 expression in Xenopus laevis
FGFR4 Gly(388)Arg polymorphism and prostate cancer risk in Scottish men
FGFR2 mutations are rare across histologic subtypes of ovarian cancer
FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC
FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Mullerian Duct
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation
FGFR2c-mediated ERK-MAPK activity regulates coronal suture development
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
FGFR3-TACC3 fusion in solid tumors: mini review
FGFR1 Induces Glioblastoma Radioresistance through the PLC gamma/Hif1 alpha Pathway
FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers
FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma
FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
FGFR4 Polymorphism as Molecular Determinant of the Efficacy of mTOR Inhibitors In GH-Secreting Pituitary Adenomas
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival
FGFR3 gene mutation plus GRB10 gene duplication in a patient with achondroplasia plus growth delay with prenatal onset
FGFR信号传导通路在特发性肺纤维化和非小细胞肺癌发病中作用机制的研究进展
FGFR4基因多态性与Luminal型乳腺癌临床病理特征的相关性
FGFR2基因多态性与黑龙江地区女性乳腺癌相关性的研究
FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model
FGFR1 Abrogates Inhibitory Effect of Androgen Receptor Concurrent With Induction of Androgen-Receptor Variants in Androgen Receptor-Negative Prostate Tumor Epithelial Cells
FGFR2基因多态性与乳腺癌易感性的相关性研究
FGFR3基因G1138A突变导致软骨发育不全
FGFR2基因SNP位点rs11200014多态性与中国女性乳腺癌易感性的关系
FGFR3 Is Overexpressed Waldenstrom Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation
FGFR3 mutations in prostate cancer: association with low-grade tumors
FGFR2 in the Dental Epithelium Is Essential for Development and Maintenance of the Maxillary Cervical Loop, a Stem Cell Niche in Mouse Incisors
FGFR2 signaling and the pathogenesis of acne
FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours
FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis
FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma
FGFR-4 Arg(388) Enhances Prostate Cancer Progression via Extracellular Signal-Related Kinase and Serum Response Factor Signaling
FGFR4 Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Mouth and Oropharynx
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
FGFR1 expression and gene copy numbers in human lung cancer
FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells
FGFR2 Mutation Confers a Less Drastic Gain of Function in Mesenchymal Stem Cells Than in Fibroblasts
FGFR2 Abnormalities Underlie a Spectrum of Bone, Skin, and Cancer Pathologies
FGFR2 as a molecular target in endometrial cancer
FGFR3 targeting strategies for achondroplasia
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis